Acepodia, Inc. (TPEX:6976)
Taiwan
· Delayed Price · Currency is TWD 16.15
-0.35 (-2.12%)
Apr 24, 2025, 1:34 PM CST
Acepodia Revenue
In the year 2024, Acepodia had annual revenue of 427.00K TWD, down -97.43%. Acepodia had revenue of 116.00K in the half year ending December 31, 2024.
Revenue
427.00K
Revenue Growth
-97.43%
P/S Ratio
22,167.82
Revenue / Employee
n/a
Employees
n/a
Market Cap
9.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 427.00K | -16.17M | -97.43% |
| Dec 31, 2023 | 16.59M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Oneness Biotech | 117.93M |
| Polaris Group | 107.00M |
| Lumosa Therapeutics | 39.15M |
| Pegavision | 6.82B |